Navigation Links
China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013
Date:6/18/2013

ed by 55.2% to RMB209.3 million ($33.7 million) from RMB134.8 million in the prior year.
  • Interest expense amounted to RMB70.1 million ($11.3 million), compared to RMB3.3 million in the prior year.
  • Net income attributable to the Company amounted to RMB112.4 million ($18.1 million), compared to RMB132.0 million in the prior year.
  • Operating cash inflow for the full year fiscal 2013 was RMB578.6 million ($93.2 million).
  • "Fiscal 2013 was a fruitful year concluded with eventful accomplishments," stated Ms. Ting Zheng, Chief Executive Officer of China Cord Blood Corporation.  "We successfully added 72,228 new subscribers to our subscriber base, finishing the year by surpassing our original target by more than 12%, and our growing accumulated subscriber base exceeded the three hundred thousand mark at 311,982.  These accomplishments were made possible by our years of market cultivation efforts and the 'Dragon Year' baby boom.  Aside from setting new records of revenue and operating cash flow, we have also raised our investment in both Guangdong and Shandong as we continue to expand our presence in China.  In addition, we are pleased that our Beijing subsidiary received AABB Accreditation as our commitment toward high quality standards has been recognized, which motivates us to strive for further quality excellence for our Group as a whole."Summary – The Fourth Quarter and Full Year Ended March 31, 2012 and 2013Three Months Ended March 31,Year Ended March 31,2012201320122013(in thousands)

    RMBRMB

    US$RMBRMB

    US$Revenues

    99,778133,011

    21,417380,490526,123

    84,711Gross Profit

    76,448106,104

    17,085293,832419,502

    67,544Operating Income

    34,84250,747

    8,172134,843209,314

    33,702Net Income Attributable to the
    Company

    29,23923,028

    3,709131,980112,447

    18,106Earnings per Ordinary Shares 
    '/>"/>

    SOURCE China Cord Blood Corporation
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

    Related biology technology :

    1. RAPS Opens Offices in Singapore and China
    2. Research Report on Chinas Diabetes Drug Market, 2013-2017
    3. Research Report on Chinas Antidepressant Market, 2013-2017
    4. Research Report on Chinas Anti-Prostatic Hyperplasia (PH) Drug Market, 2013-2017
    5. China Cord Blood Corporation to Report Fourth Quarter and Full Year of Fiscal 2013 Financial Results
    6. Elsevier Signs Strategic Collaboration Agreement with Peoples Medical Publishing House, China
    7. Infinata's BioPharm Insight Global Editor Kim Ha to Moderate Panel at 3rd Annual U.S.-China Conference on Strategies for Mining Profits from Pharma Opportunities in China
    8. China Engineering Plastics Industry will Reach US$5 Million By 2017 - Engineering Plastics Market, Share, Size, Analysis, Market Scale, Competition and Forecast 2013-2017
    9. China Industry Reports: 2013 Research on Swine Industry Chain, Human Tetanus Immunoglobulin, Power Energy Storage Battery and Wind Power Lubricating Grease at ReportsnReports.com
    10. Future Course of New Lethal Avian Flu Outbreak in China Can Be Predicted
    11. China Cord Blood Corporation Received AABB Accreditation
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:9/19/2014)... than electricity, to move data would consume much ... growing concern as chips, transistor counts rise. , ... light emitters, modulators, and detectors emitters ... source for optical chips is molybdenum disulfide (MoS2), ... a single, atom-thick layer. Other experimental on-chip light ...
    (Date:9/19/2014)... 2014  An entire month is dedicated to one ... Charcot-Marie-Tooth disease (CMT) – a debilitating neuromuscular disease affecting ... atrophy, weakness, and foot and hand deformities. CMT affects ... CMT is a progressive disease, and over time patients ... devices such as leg braces, wheelchairs and scooters to ...
    (Date:9/19/2014)... 2014  Nektar Therapeutics (NASDAQ: NKTR ... the analgesic profiles of a series of the ... molecules. The preclinical research candidates were created using ... The analgesic properties of kappa receptor agonism ... Kappa opioid receptors are expressed in the ...
    (Date:9/19/2014)... Florida , September 19, 2014 ... release latest developments, patents and results of studies and ... Eli Lilly and Company (NYSE: LLY ), ... Corporation (NASDAQ: CELG ) and Arena Pharmaceuticals ... a leader in developing prodrug therapeutics for the treatment ...
    Breaking Biology Technology:Toward optical chips 2Toward optical chips 3September is Charcot-Marie-Tooth (CMT) Awareness Month - Scheduled events, activities and important partnerships announced throughout the month! 2Nektar Presents Positive Preclinical Data on Oral, Peripherally-Acting Kappa Agonist Molecules at 2014 American Academy of Pain Management Meeting 2Nektar Presents Positive Preclinical Data on Oral, Peripherally-Acting Kappa Agonist Molecules at 2014 American Academy of Pain Management Meeting 3Nektar Presents Positive Preclinical Data on Oral, Peripherally-Acting Kappa Agonist Molecules at 2014 American Academy of Pain Management Meeting 4Nektar Presents Positive Preclinical Data on Oral, Peripherally-Acting Kappa Agonist Molecules at 2014 American Academy of Pain Management Meeting 5Biotech Companies Pushing Sector Higher With Recent Therapeutic Advancements & Patent Approvals - Company Wins Summary Judgment For Prodrug Patent 2Biotech Companies Pushing Sector Higher With Recent Therapeutic Advancements & Patent Approvals - Company Wins Summary Judgment For Prodrug Patent 3Biotech Companies Pushing Sector Higher With Recent Therapeutic Advancements & Patent Approvals - Company Wins Summary Judgment For Prodrug Patent 4Biotech Companies Pushing Sector Higher With Recent Therapeutic Advancements & Patent Approvals - Company Wins Summary Judgment For Prodrug Patent 5Biotech Companies Pushing Sector Higher With Recent Therapeutic Advancements & Patent Approvals - Company Wins Summary Judgment For Prodrug Patent 6Biotech Companies Pushing Sector Higher With Recent Therapeutic Advancements & Patent Approvals - Company Wins Summary Judgment For Prodrug Patent 7
    ... YORK, March 16, 2011 Reportlinker.com announces that ... its catalogue: Global Growth ... http://www.reportlinker.com/p0397766/Global-Growth-Factors--Blood-And-Tissue--Industry.html ... Factors (Blood And Tissue) in US$ Million by ...
    ... Three scientists whose pioneering work in isolating human stem ... been named the recipients of the 11th annual Albany Medical ... Elaine Fuchs, Ph.D., the Rebecca C. Lancefield ... Development, and a Howard Hughes Medical Institute investigator at The ...
    ... SAN JOSE, Calif., March 16, 2011 Finesse ... measurement and control solutions for life sciences process ... processing platform for single-use bioreactors ranging from 25L ... turn-key control systems is designed to the highest ...
    Cached Biology Technology:Global Growth Factors ( Blood And Tissue ) Industry 2Global Growth Factors ( Blood And Tissue ) Industry 3Global Growth Factors ( Blood And Tissue ) Industry 4Global Growth Factors ( Blood And Tissue ) Industry 5Global Growth Factors ( Blood And Tissue ) Industry 6Global Growth Factors ( Blood And Tissue ) Industry 7Global Growth Factors ( Blood And Tissue ) Industry 8Global Growth Factors ( Blood And Tissue ) Industry 9Global Growth Factors ( Blood And Tissue ) Industry 10Global Growth Factors ( Blood And Tissue ) Industry 11Global Growth Factors ( Blood And Tissue ) Industry 12Global Growth Factors ( Blood And Tissue ) Industry 13Global Growth Factors ( Blood And Tissue ) Industry 14Global Growth Factors ( Blood And Tissue ) Industry 15Global Growth Factors ( Blood And Tissue ) Industry 16Leaders in Stem Cell Research and Discovery to Share America's Most Distinguished Prize in Medicine 2Leaders in Stem Cell Research and Discovery to Share America's Most Distinguished Prize in Medicine 3Leaders in Stem Cell Research and Discovery to Share America's Most Distinguished Prize in Medicine 4Leaders in Stem Cell Research and Discovery to Share America's Most Distinguished Prize in Medicine 5Finesse Solutions Introduces New T700 cGMP Upstream Processing Platform Featuring G3 Hardware and Fully Integrated Single-Use Sensors 2
    (Date:9/19/2014)... University of Oklahoma biology professor will study the unique ... that could eventually benefit people,s health. The OU ... the energy required to produce the signals used to ... electric signals at a rate of 500-600 discharges a ... for the electric fish are extreme, but necessary for ...
    (Date:9/19/2014)... 2014 Nxt-ID, Inc. (Nasdaq: NXTD and ... the growing m-commerce market, updates the "Wocket in Your Pocket" celebrity ... and light middleweight weight classes, Vinny Pazienza (PAZ). ... Game of Thrones actor Ciaran Hinds and ... star Katey Sagal have been cast in Bleed ...
    (Date:9/18/2014)... A sleep-promoting circuit located deep in the primitive brainstem ... by researchers at Harvard School of Medicine and the ... this is only the second "sleep node" identified in ... necessary and sufficient to produce deep sleep. , Published ... study demonstrates that fully half of all of the ...
    Breaking Biology News(10 mins):NXT-ID's Vinny Paz Celebrity Ad Wocket Update: Katey Sagal and Ciaran Hinds Attached to His Upcoming Movie 2NXT-ID's Vinny Paz Celebrity Ad Wocket Update: Katey Sagal and Ciaran Hinds Attached to His Upcoming Movie 3No sedative necessary: Scientists discover new 'sleep node' in the brain 2
    ... human corneas restore transparency and don,t trigger a rejection ... hazy, according to experiments conducted in mice by researchers ... study will be published in the journal Stem ... suggest that cell-based therapies might be an effective way ...
    ... been widely regarded as contributing to autoimmune disease, but ... that low levels of vitamin D in patients with ... cause of disease and that supplementing with vitamin D ... team of researchers at the California-based non-profit Autoimmunity Research ...
    ... Engineers at Oregon State University have discovered a way to ... newest technologies for solar energy, in systems that may be ... The secret: diatoms. These tiny, single-celled marine life ... are the basis for much of the life in the ...
    Cached Biology News:Stem cell therapy makes cloudy corneas clear, according to Pitt researchers 2Vitamin D may exacerbate autoimmune disease 2Ancient diatoms lead to new technology for solar energy 2
    ... for analytical performance , ... the ultimate in analytical,performance, the ... 810-MS features include: , ... providing reliable, routine, trace level,quantification. ...
    ... of urine will give a positive reaction for ... The Donors are of US origin and ... for HbsAg, HCV, HIV-1 & 2, Syphilis and ... MATERIAL IS SOLD FOR IN-VITRO DIAGNOSTIC USE ONLY ...
    ... OPTIMA is a fully automated microplate ... the widest possible range of applications ... gene assays luciferase, -galactosidase, gene activities ... dioxetanes..) Luminescent Immunoassays Cell-based ...
    ... dispensers save space and organize gloves, ... garb. They are the perfect benchtop ... in labs, processing and manufacturing. Clear ... the particles they attract. Open-slot design ...
    Biology Products: